Cancer

Showing NaN - NaN of 80

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Brain Tumor, Cancer Trial run by the National Cancer Institute (NCI) (Zotiraciclib)

Not yet recruiting
  • Brain Tumor
  • Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

NIH-AARP Diet and Health Secondary Research Study Based on

Active, not recruiting
  • Cancer
  • +2 more
    • Bethesda, Maryland
      National Cancer Institute (NCI)
    Feb 2, 2023

    Collection of Tissue Blocks or Slides From Patients With Cancer

    Recruiting
    • Tumor
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 28, 2023

      Patient-Specific Genotypes and Phenotypes That Influence Drug

      Enrolling by invitation
      • Cancer
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 28, 2023

        Patients Receiving Radiation Therapy for Brain Metastases

        Recruiting
        • Brain Metastasis
        • Cancer
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 27, 2023

          Blood and Urine From Patients Undergoing Radiation Therapy

          Enrolling by invitation
          • Carcinoma
          • +2 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Jan 26, 2023

            Voicing My CHOiCES asTool for Advanced Care Planning in Young

            Recruiting
            • HIV
            • +3 more
              • Orange, California
              • +9 more
              Jan 26, 2023

              Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

              Recruiting
              • Tumor
              • +20 more
              • Mobile, Alabama
              • +81 more
              Jan 24, 2023

              Natural History of Disease in Patients Treated With Radiotherapy

              Recruiting
              • Cancer
                • Bethesda, Maryland
                  National Institutes of Health Clinical Center
                Jan 25, 2023

                d by Cancer Patients Receiving Primary Treatment and Cancer

                Recruiting
                • Cancer
                • +4 more
                  • Bethesda, Maryland
                    National Institutes of Health Clinical Center
                  Jan 23, 2023

                  Patient-Centered Assessment of Symptoms and Outcomes

                  Recruiting
                  • Fatigue
                  • +7 more
                    • Bethesda, Maryland
                      National Institutes of Health Clinical Center
                    Jan 23, 2023

                    Family Genetics Health Education and Healthy Behaviors

                    Completed
                    • Diabetes
                    • +2 more
                      • Bethesda, Maryland
                        National Institutes of Health Clinical Center
                      Jan 20, 2023

                      Tumor Related Epilepsy

                      Recruiting
                      • Epilepsy
                      • +2 more
                        • Bethesda, Maryland
                          National Institutes of Health Clinical Center
                        Jan 18, 2023

                        Connect for Cancer Prevention Study (Connect)

                        Recruiting
                        • Cancer
                        • General Research Use
                          • Denver, Colorado
                          • +9 more
                          Jan 7, 2023

                          Cancer Trial run by the NHGRI (A, B)

                          Completed
                          • Cancer
                          • A
                          • B
                          • Bethesda, Maryland
                            National Institutes of Health Clinical Center
                          Jan 6, 2023

                          NSCLC, Anemia, Cancer Trial in Worldwide (Darbepoetin alfa, Placebo)

                          Terminated
                          • Non-Small Cell Lung Cancer
                          • +3 more
                          • Darbepoetin alfa
                          • Placebo
                          • Anniston, Alabama
                          • +566 more
                          Nov 4, 2022

                          Clinical, Laboratory, and Epidemiologic Characterization of

                          Active, not recruiting
                          • Hereditary Neoplasms
                          • +3 more
                            • Bethesda, Maryland
                              National Institutes of Health Clinical Center
                            Nov 18, 2022

                            Improving Cancer Symptom Management

                            Recruiting
                            • Cancer
                            • +3 more
                              • Baltimore, Maryland
                              • +3 more
                              Sep 1, 2022

                              Samples From People With Unanticipated Response, Significant

                              Enrolling by invitation
                              • Cancer
                              • +2 more
                                • Bethesda, Maryland
                                  National Institutes of Health Clinical Center
                                Aug 24, 2022

                                Rare Tumors and Cancer Predisposition in Individuals and

                                Recruiting
                                • Cancer
                                • +3 more
                                  • Bethesda, Maryland
                                  • +1 more
                                  Aug 24, 2022

                                  Data Collection, Clinical Care and Interventions in CCR, NCI

                                  Enrolling by invitation
                                  • Neoplasms
                                  • Cancer
                                    • Bethesda, Maryland
                                      National Institutes of Health Clinical Center
                                    Aug 20, 2022

                                    Omics of Cancer: OncoGenomics

                                    Not yet recruiting
                                    • Neoplasms
                                    • Cancer
                                      • Bethesda, Maryland
                                        National Institutes of Health Clinical Center
                                      Aug 17, 2022

                                      Metabolic Sizing in Health and Disease

                                      Not yet recruiting
                                      • Metabolic Disorders
                                      • +4 more
                                        • Bethesda, Maryland
                                          National Institutes of Health Clinical Center
                                        Aug 17, 2022

                                        Cancer, Solid Tumor, Metastatic Checkpoint Refractory HPV Associated Malignancies Trial run by the National Cancer Institute

                                        Recruiting
                                        • Cancer
                                        • +3 more
                                        • Bintrafusp Alfa
                                        • +2 more
                                        • Bethesda, Maryland
                                          National Institutes of Health Clinical Center
                                        Aug 11, 2022

                                        Checking Out Checking In: The Development and Validation

                                        Recruiting
                                        • Cancer
                                          • Aurora, Colorado
                                          • +3 more
                                          Jul 6, 2022